ATYR Earnings aTYR PHARMA INC
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–25 of 25
| Q2 2026 | 2026-06-30 | -0.22 | 2026-08-07 | 10-Q |
| Q1 2026 | 2026-03-31 | -0.11 | 2026-05-15 | 10-Q |
| FY 2025 | 2025-12-31 | -0.80 | 2026-03-05 | 10-K |
| Q3 2025 | 2025-09-30 | -0.66 | 2025-11-06 | 10-Q |
| Q2 2026 | 2025-06-30 | -0.39 | 2026-08-07 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.17 | 2026-05-15 | 10-Q |
| FY 2025 | 2024-12-31 | -0.86 | 2026-03-05 | 10-K |
| Q3 2025 | 2024-09-30 | -0.69 | 2025-11-06 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.46 | 2025-08-07 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.23 | 2025-05-07 | 10-Q |
| FY 2025 | 2023-12-31 | -0.94 | 2026-03-05 | 10-K |
| Q3 2024 | 2023-09-30 | -0.69 | 2024-11-07 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.50 | 2024-08-13 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.29 | 2024-05-02 | 10-Q |
| FY 2024 | 2022-12-31 | -1.60 | 2025-03-13 | 10-K |
| Q3 2023 | 2022-09-30 | -1.34 | 2023-11-09 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.88 | 2023-08-09 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.44 | 2023-05-09 | 10-Q |
| FY 2023 | 2021-12-31 | -1.77 | 2024-03-14 | 10-K |
| Q3 2022 | 2021-09-30 | -1.56 | 2022-11-14 | 10-Q |
| Q2 2022 | 2021-06-30 | -1.16 | 2022-08-15 | 10-Q |
| Q1 2021 | 2021-03-31 | -0.51 | 2021-05-14 | 10-Q |
| FY 2022 | 2020-12-31 | -1.77 | 2023-03-14 | 10-K |
| Q1 2021 | 2020-03-31 | 0.25 | 2021-05-14 | 10-Q |
| Q1 2020 | 2019-03-31 | -2.54 | 2020-05-12 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.